Avalo Therapeutics, Inc.
AVTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534120
In the last 90 days, Avalo Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $1.31B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Avalo Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +4 vs. Q3 2024
- Shares held
- 7.53M
- +873.6K (+13.1%) vs. Q3 2024
- Total value
- $56.0M
- −$7.25M (−11.5%) vs. Q3 2024
- New holders
- 9
- 8 more added
- Sold out
- 5
- 3 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 126 | $1.31B |
| Q1 2026 | 97 | $469.6M |
| Q4 2025 | 84 | $361.1M |
| Q3 2025 | 66 | $194.7M |
| Q2 2025 | 36 | $39.1M |
| Q1 2025 | 34 | $66.1M |
| Q4 2024 | 33 | $56.0M |
| Q3 2024 | 29 | $63.2M |
| Q2 2024 | 21 | $9.62M |
| Q1 2024 | 18 | $1.90M |
| Q4 2023 | 12 | $209.4K |
| Q3 2023 | 28 | $158.9K |
| Q2 2023 | 26 | $862.7K |
| Q1 2023 | 32 | $16.0M |
| Q4 2022 | 28 | $28.0M |
| Q3 2022 | 27 | $18.4M |
| Q2 2022 | 54 | $34.7M |
| Q1 2022 | 71 | $56.2M |
| Q4 2021 | 75 | $136.0M |
| Q3 2021 | 77 | $175.5M |
| Q2 2021 | 71 | $218.1M |
| Q1 2021 | 70 | $180.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Avalo Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Parallel Advisors, LLC | 1 | $7 | 0.00% | 00.0% | Unchanged |
| Key Financial Inc | 1 | $7 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 1 | $7 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2 | $14 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2 | $15 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2 | $15 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 4 | $30 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 10 | $74 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 22 | $163 | 0.00% | +22 | New |
| Tower Research Capital LLC (TRC) | 4,130 | $30.7K | 0.00% | +3,754+998.4% | Added |
| Bank of America Corp | 5,670 | $42.1K | 0.00% | +69+1.2% | Added |
| Marshall Wace, LLP | 15,323 | $113.8K | 0.00% | +15,323 | New |
| Walleye Capital LLC | 19,477 | $144.7K | 0.00% | +19,477 | New |
| Northern Trust Corp | 22,673 | $168.5K | 0.00% | +22,673 | New |
| HRT Financial LP | 40,000 | $297.0K | 0.00% | +40,000 | New |
| Bank of Montreal | 60,000 | $445.8K | 0.00% | +60,000 | New |
| Sio Capital Management, LLC | 71,458 | $530.9K | 0.15% | 00.0% | Unchanged |
| Allostery Investments LP | 73,314 | $544.7K | 1.07% | +73,314 | New |
| UBS Group AG | 98,519 | $732.0K | 0.00% | +92,385+1,506.1% | Added |
| Geode Capital Management, LLC | 104,853 | $779.1K | 0.00% | +94,742+937.0% | Added |
| Velan Capital Investment Management LP | 109,972 | $817.1K | 0.71% | +109,972 | New |
| Royal Bank of Canada | 117,356 | $872.0K | 0.00% | +117,356 | New |
| BlackRock, Inc. | 133,235 | $989.9K | 0.00% | +132,906+40,397.0% | Added |
| Boothbay Fund Management, LLC | 163,992 | $1.22M | 0.04% | −100−0.1% | Reduced |
| Vanguard Group Inc | 165,801 | $1.23M | 0.00% | +155,433+1,499.2% | Added |
| Commodore Capital LP | 483,000 | $3.59M | 0.26% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 483,000 | $3.59M | 0.35% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 550,765 | $4.09M | 0.64% | +505,765+1,123.9% | Added |
| Deep Track Capital, LP | 867,000 | $6.44M | 0.24% | −100,000−10.3% | Reduced |
| OrbiMed Advisors LLC | 967,000 | $7.18M | 0.15% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 967,000 | $7.18M | 0.10% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 970,259 | $7.21M | 2.06% | −1000.0% | Reduced |
| BVF Inc | 1,036,679 | $7.70M | 0.26% | +69,679+7.2% | Added |
| Logos Global Management LP | 0 | $0 | 0.00% | −539,079−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Jaffetilchin Investment Partners, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −5−100.0% | Sold out |